Attenuated ability of BACE1 to cleave the amyloid precursor protein via silencing long noncoding RNA BACE1‑AS expression
- Authors:
- Te Liu
- Yongyi Huang
- Jiulin Chen
- Huiying Chi
- Zhihua Yu
- Jian Wang
- Chuan Chen
View Affiliations
Affiliations: Central Laboratory, Shanghai Geriatric Institute of Chinese Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200031, P.R. China, Central Laboratory, School of Life Science and Technology, Tongji University, Shanghai 200092, P.R. China
- Published online on: June 23, 2014 https://doi.org/10.3892/mmr.2014.2351
-
Pages:
1275-1281
-
Copyright: © Liu
et al. This is an open access article distributed under the
terms of Creative
Commons Attribution License [CC BY_NC 3.0].
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Although large numbers of long noncoding RNAs (lncRNAs) expressed in the mammalian nervous system have been detected, their functions and mechanisms of regulation remain to be fully clarified. It has been reported that the lncRNA antisense transcript for β‑secretase‑1 (BACE1‑AS) is elevated in Alzheimer's disease (AD) and drives the rapid feed‑forward regulation of β‑secretase, suggesting that it is critical in AD development. In the present study, the senile plaque (SP) AD SH‑SY5Y cell model was established using the synthetic amyloid β‑protein (Aβ) 1‑42 in vitro. Using this model, the potential of siRNA‑mediated silencing of lncRNA BACE1‑AS expression to attenuate the ability of β‑secretase‑1 (BACE1) to cleave amyloid precursor protein (APP) and to reduce the production of Aβ1‑42 oligomers was investigated. MTT assays demonstrated that exogenous Aβ1‑42 suppressed SH‑SY5Y cell proliferation and induced APP‑related factor expression and SP formation. Furthermore, quantitative polymerase chain reaction and western blot analysis revealed that the mRNA and protein expression of Aβ1‑42 and Aβ1‑40 was significantly increased in the AD model group, with a marked decrease in Ki‑67 expression at day six. RNase protection assays (RPA) and northern blotting analysis confirmed that exogenous Aβ1‑42 not only promoted the expression of the APP‑cleaving enzyme BACE1, but also induced lncRNA BACE1‑AS expression. Furthermore, lncRNA BACE1‑AS formed RNA duplexes and increased the stability of BACE1 mRNA. Downregulation of lncRNA BACE1‑AS expression in SH‑SY5Y cells by siRNA silencing resulted in the attenuation of the ability of BACE1 to cleave APP and delayed the induction of SP formation in the SP AD SH‑SY5Y cell model.
View References
1
|
Wilusz JE, Sunwoo H and Spector DL: Long
noncoding RNAs: functional surprises from the RNA world. Genes Dev.
23:1494–1504. 2009. View Article : Google Scholar : PubMed/NCBI
|
2
|
Huarte M: LncRNAs have a say in protein
translation. Cell Res. 23:449–451. 2013. View Article : Google Scholar : PubMed/NCBI
|
3
|
Tsai MC, Manor O, Wan Y, et al: Long
noncoding RNA as modular scaffold of histone modification
complexes. Science. 329:689–693. 2010. View Article : Google Scholar : PubMed/NCBI
|
4
|
Caley DP, Pink RC, Trujillano D and Carter
DR: Long noncoding RNAs, chromatin, and development. Scientific
World Journal. 10:90–102. 2010. View Article : Google Scholar : PubMed/NCBI
|
5
|
Johnson R: Long non-coding RNAs in
Huntington’s disease neurodegeneration. Neurobiol Dis. 46:245–254.
2012.
|
6
|
Qureshi IA, Mattick JS and Mehler MF: Long
non-coding RNAs in nervous system function and disease. Brain Res.
1338:20–35. 2010. View Article : Google Scholar : PubMed/NCBI
|
7
|
Faghihi MA, Modarresi F, Khalil AM, et al:
Expression of a noncoding RNA is elevated in Alzheimer’s disease
and drives rapid feed-forward regulation of beta-secretase. Nat
Med. 14:723–730. 2008.
|
8
|
Isobe I, Yanagisawa K and Michikawa M: A
possible model of senile plaques using synthetic amyloid
beta-protein and rat glial culture. Exp Neurol. 162:51–60. 2000.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Querfurth HW and LaFerla FM: Alzheimer’s
disease. N Engl J Med. 362:329–344. 2010.
|
10
|
Liu T, Shen D, Xing S, et al: Attenuation
of exogenous angiotensin II stress-induced damage and apoptosis in
human vascular endothelial cells via microRNA-155 expression. Int J
Mol Med. 31:188–196. 2013.
|
11
|
Liu T, Cheng W, Huang Y, Huang Q, Jiang L
and Guo L: Human amniotic epithelial cell feeder layers maintain
human iPS cell pluripotency via inhibited endogenous microRNA-145
and increased Sox2 expression. Exp Cell Res. 318:424–434. 2012.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Cheng W, Liu T, Jiang F, et al:
microRNA-155 regulates angiotensin II type 1 receptor expression in
umbilical vein endothelial cells from severely pre-eclamptic
pregnant women. Int J Mol Med. 27:393–399. 2011.PubMed/NCBI
|